Developer of a miniature biosensing device intended to use a small blood volume to derive data on multiple biomarkers present in the sample.
eGlint has raised $2.4M in total funding. The most recent round was Seed. The last funding was announced in November 2021.
eGlint's investors include Breakthrough Energy Ventures, Ulu Ventures, Half Court Ventures, Emerald Bioventures, SeedFolio.
eGlint is headquartered in San Diego, United States.
Developer of a miniature biosensing device intended to use a small blood volume to derive data on multiple biomarkers present in the sample.
eGlint is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"eGlint — Funding & Investors." VCBacked, November 12, 2021, https://www.vcbacked.co/company/eglint. Accessed July 19, 2026.
VCBacked. (2021). eGlint — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/eglint
{{cite web |title=eGlint — Funding & Investors |url=https://www.vcbacked.co/company/eglint |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated